stemcell medical center head

Dr Kampon Sriwatanakul MD PhD

dr-kamon-Sriwatanakul-regen

Medical Degree:

  • B.Sc. 1972 Mahidol University Medical Science
  • M.D. 1974 Mahidol University Medicine (with Honors)
  • Ph.D. 1978 Mahidol University Pharmacology

Present Posts:

Previous Medical Posts

  • Ramathibodi Hospital : April 1974 – April 1975 – Lecturer, Department of Pharmacology, Faculty of Science
  • Mahidol University : May 1975 – August 1979 – Assistant Professor, Department of Pharmacology, Faculty of Science
  • Mahidol University : August 1979 – July 1985 – Chairman, Department of Pharmacology, Faculty of Science
  • Mahidol University : April 1984 – March 1988 – Director, Toxicology Graduate Program
  • Faculty of Graduate Studies, Mahidol University – June 1984 – January 1989
  • Deputy Dean, Faculty of Graduate Studies, Mahidol University August 1988 – January 1989
  • Assistant to the President on Foreign Relations and Research – Mahidol University : February 1989 – April 1990
  • Vice President on Research and Foreign Relations, Mahidol University – May 1990 – December 1991
  • Deputy Dean, Faculty of Graduate Studies, Mahidol University – January 1992 – April 1995

Other Institutional Posts :

  • Adjunct Scholar, Centre for the Study of Drug Development – Tufts University, Boston, USA
  • Member, The Medical Association of Thailand
  • Member, The Pharmacological and Therapeutic Society of Thailand
  • Member, The Toxicological Society of Thailand

Academic and Research Awards :

  • British Council Research Fellow in Pharmacology – University of Leicester, Leicester, UK – September 1978 – July 1979
  • Merck International Fellow in Clinical Pharmacology – University of Rochester, Rochester, New York, USA – January 1981 – December 1982
  • British Council Visiting Scientist – Department of Clinical Pharmacology
  • University of Edinburgh, Edinburgh, UK – December 1987 – June 1988
  • UICC : Yamagiwa-Yoshisa Memorial International Cancer Study Grants
  • Institute of Cancer Research – The Royal Marsden Hospital, Sutton, UK – November 1988 – January 1989

Current Research Interests :

  • Clinical Trials of New Pharmacokinetics
  • Clinical Pharmacokinetics
  • Development of Traditional Thai Herbal Medications
  • Pharmacoepidemiology
  • Neuromuscular Disorders

 

Previous Medical Journal,Publications and Communications :

1. Nahorski, SR and SRIWATANAKUL, K (1979) Analysis of the activity and distribution of beta-adrenoceptor antagonists using an ex vivo receptor binding assay. (Proceedings) Br. J. Pharmacol. 67: 415P

2. SRIWATANAKUL, Kamol and Nahorski, SR (1980) Disposition and activity of beta-adrenoceptor antagonists using an ex-vivo receptor binding assy. Eur. J. Pharmacol. 66: 169-178 [1]

3. SRIWATANAKUL, K and Weintraub, M (1981) Analgesic use in the treatment of cancer pain. Thai Cancer J. 7: 111-116

4. SRIWATANAKUL, K (1981) Lowering of seizure threshold induced by phenothiazine therapy. Thai J. Pharmacol. 3: 95-100

5. Weis, O and SRIWATANAKUL, K (1982) Methotrimeprazine analgesia. Drug Therapy. 12: 143-147

6. SRIWATANAKUL, K and Weintraub, M (1982) Food-drug interaction: an overlooked clinical problem. Drug Therapy. 12: 157-159 [2]

7. SRIWATANAKUL, K (1982) Minimizing the risk of antipsychotic associated seizures. Drug Therapy. 12: 207-250 OrcID

8. SRIWATANAKUL, K and Weis, O (1982) Using antipsychotic drugs in pregnancy. Drug Therapy. 12: 247-250 [3]

9. Weis, O, SRIWATANAKUL, K. and Weintraub, M (1982) Methotrimeprazine in acute porpyria. South African Med. J. 61: 985-986

10. Weis, O, SRIWATANAKUL, K and Weintraub, M (1982) Treatment of post-herpetic neuralgia and acute herpetic pain with amitryptyline and perphenazine. South African Med. J. 62: 274-275

11. Calimlim, JF, Wardell, WM, SRIWATANAKUL, K, Lasagna, L and Cox, C (1982) Analgesic efficacy of parenteral metkephamid acetate in the treatment of postoperative pain. Lancet 1: 1374-1375

12. SRIWATANAKUL, K, Kelvin, W and Lasagna, L (1982) The quantification of pain : an analysis of words used to describe pain and analgesia in clinical trials. Clin. Pharmacol Ther. 32: 143-148

13. SRIWATANAKUL, K (1982) A critical examination of drug interactions. Thai J. Pharmacol. 4: 17-35 [4]

14. SRIWATANAKUL, K (1982) A critical examination of drug interactions. Thai J. Pharmacol. 4: 143-151 [5]

15. SRIWATANAKUL, K and Weintraub, M (1983) Understanding food-drug interactions. Comprehensive Therapy. 9: 6-11

16. Weis, OF, SRIWATANAKUL, K, Alioza, JL Weintraub, M and Lasagna, L (1983) Attitudes of patients, housestaff and nurses towards post-operative analgesic care. Anesth. Anlgesia. 62: 70-74 [6]

17. Weis, OF SRIWATANAKUL, K. Weintraub, M and Lasagna, L (1983) Reduction of anxiety and postoperative analgesic requirements by audiovisual instruction. Lancet 1: 43-44 [7]

18. Weintraub, M, SRIWATANAKUL, K, Sundaresan, PR, Weis, OF and Dorn, M (1983) Extended-release fenfluramine: patient acceptance and efficacy f evening dosing. Clin. Pharmacol. Ther. 33: 621-627

19. SRIWATANAKUL, K and Mehta, G (1983) Update review of clinically significant drug interactions. Drug Therapy. 13” 41-44

20. Wang, ZX and SRIWATANAKUL, K (1983) Drugs used for the treatment of dementia. Rational Drug Therapy.17: 1-4

21. SRIWATANAKUL, K, Kelvin, W, Lasagna, L, Calimlim, JF, Weis, OF and Mehta, G (1983) Studies with different types of visual analog scales for measurement of pain. Clin. Pharmacol. Ther. 34: 234-239 [8]

22. SRIWATANAKUL, K, lasagna, 1 and Cox, C (1983) Evaluation of current clinical trial methodology in analgesimetry based on experts opinions and analysis of several analgesic studies. Clin. Pharmacol. Ther.34: 277-283 [9]

23. SRIWATANAKUL, K (1983) Long-term follow-up of a clinical trial of anorexiant drugs. Thai J. Pharmacol. 5: 163-172

24. SRIWATANAKUL, K, Weis, OF, Allozo, JL, Keivn, W, Weintraub, M and Lasagna, L (1983).

25. Makarananda, K and SRIWATANAKUL, K (1983) Cancer chemotherapy : Drug interaction. Thai Cancer J. 9: 55-59

26. Pothisiri, P, Makarananda, K, SRIWATANAKUL, K, Chroonroj, P, Pongprayoon, U and Eamungroj, S (1984)Prospective study of adverse reactions of antiepileptic drugs in Thai outpatients. Thai J. Pharmacol. 6: 1-10

27. Makarananda, K, SRIWATANAKUL, K, Pothsiri, P, Eamrungroj, S, Charoonroj, P and Pongprayoon, U (1985)Prospective study of adverse drug reactions of antihypertensive drugs in Thai outpatients. J. Med. Ass. Thailand. 68: 229-236

28. Yoovathawon, KC, SRIWATANAKUL, K and Thithapandha, A (1986) Influence of caffeine on aspirin pharmacokinetics. Eur. J.Drug Metab. Pharmacokinet. 11: 71-76

29. Unchern, S, Unchern, S, Chumsawat, P, SRIWATANAKUL, K and Limsuwan, A (1986) Psychomotor performances and subjective feeling studies with antihistamines. J. Med. Association. Thailand. 69: 203-209

30. SRIWATANAKUL, K and Pothisiri, P (1986) Adverse reaction assessment in Thailand. Med. Toxicol. 1(suppl 1): 105-109

31. SRIWATANAKUL, K (1987) Need for chemicals safety information in Thailand. J. Toxicol. Sci. 12: 285-286 [10]

32. Yanapirut, P and SRIWATANAKUL, K (1987) Prospective study of adverse reactions of anticancer drugs in Thai patients. J. Med. Association of Thailand. 70: 448-454

33. SRIWATANAKUL, K (1988) Mechanism of action of anorexiant agents-Amphetamine and other drugs.Medicographia. 10:22-23

34. Critchley, JA, Makarananda, K, Balali-Mood, M. SRIWATANAKUL, K and Lee, MR (1988) Further ethnic differences in the renal dopamine relationship : its uncoupling in the Iranian but not in Thai normotensive subject. J. Hypertension 6(suppl 4): S623-S625  [11]

35. Komindr, S, SRIWATANAKUL, K and Sriwatanakul, K (1988) Double-blind comparison study to determine the efficacy and safety of dexfenfluramine in the treatment of obese patients. Intern. Med. 4: 65-68

36. SRIWATANAKUL, K (1989) Trials of dipyrone in Thailand. Lancet. 1: 788 [12]

37. Critchley, JA, Lee, MR, Gordon, CJ, Makarananda, K, SRIWATANAKUL, K, Balali-Mood, M and Boye, GL (1989) Ethnic differences in the renal sodium-dopamine relationship : a possible explanation for regionai variation in the prevalence of hypertension? Eur. J. Clin. Pharmacol. 37: 559-562 [13]

38. Critchley, JA, SRIWATANAKUL, K, Charuchinda, C, Balali-Mood, M, Boye. GL, Chan, TY, Brocklesby, NC and Lee MR (1990) Ethnic difference in the renal dopamine response to an oral salt load. J. Human Hypertension. 4: 91-93 [14]

39. Lee, MR, Critchley, JA, Gordon, CJ, Makarananda, K, SRIWATANAKUL, K, Balali-Moods, M and Boye, GL (1990) Ethnic differences in the renal sodium-dopamine relationship : a possible explanation for regional variation in the prevalence of hypertension? Am. J. Hypertension. 3: 100S-103S

40. Prescott, LF, Yoovathaworn, K, Makarananda, K, Saivises, R and SRIWATANAKUL, K (1993) Imparied absorption of paracetamol in vegetarians. Br. J. Clin. Pharmac. 36: 237-240  [15]

41. SRIWATANAKUL, K and Sriwatanakul, K (1995) The efficacy and side effects of antiflatulents in the treatment of functional dyspepsia. Naresuan University J. 3: 1-4

42. Makarananda, K, Pengpan, U, Srisakulthong, M, Yoovathaworn, K and SRIWATANAKUL, K (1998) Monitoring of aflatoxin exposure by biomarkers. J. Toxicol. Sciences 23: (Suppl 11) 155-159

43. Muangman, V, Thithapanda, A Yoovathaworn, K, Supavilai, P, Arunnopparat, W and SRIWATANAKUL, K (1998) A study on diuretic effects of Pluchea indica in man. Thai. J. Urol. 19: 116-128

Published Clinical Citations

  • [1] ^ Critchley, J A, K Sriwatanakul, C Charuchinda, M Balali-Mood, G L Boye, T Y Chan, N C Brocklesby, and M R Lee. 1990. Ethnic differences in the renal dopamine response to an oral salt load. Journal of human hypertension, no. 2. >

  • [2] ^ Sriwatanakul, K, K McCormick, and P Woolf. 1984. Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists. The Journal of clinical endocrinology and metabolism, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/6420433

  • [3] ^ Jeenapongsa, Rattima, Krongtong Yoovathaworn, Kittima M Sriwatanakul, Ubonwan Pongprayoon, and Kampon Sriwatanakul. 2003. Anti-inflammatory activity of (E)-1-(3,4-dimethoxyphenyl) butadiene from Zingiber cassumunar Roxb. Journal of ethnopharmacology, no. 2-3. https://www.ncbi.nlm.nih.gov/pubmed/12860299

  • [4] ^Makarananda, K, U Pengpan, M Srisakulthong, K Yoovathaworn, and K Sriwatanakul. 1998. Monitoring of aflatoxin exposure by biomarkers. The Journal of toxicological sciences. https://www.ncbi.nlm.nih.gov/pubmed/9760454

  • [5] ^ McCormick, K, V J Notar-Francesco, and K Sriwatanakul. 1983. Inhibition by acetyl-CoA of hepatic carnitine acyltransferase and fatty acid oxidation. The Biochemical journal, no. 2 ( 15). https://www.ncbi.nlm.nih.gov/pubmed/6661211

  • [6] ^ Prescott, L F, K Yoovathaworn, K Makarananda, R Saivises, and K Sriwatanakul. 1993. Impaired absorption of paracetamol in vegetarians. British journal of clinical pharmacology, no. 3. https://www.ncbi.nlm.nih.gov/pubmed/9114910.

  • [7] ^ Sriwatanakul, K. 1987. Need for chemicals safety information in Thailand. The Journal of toxicological sciences, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/3625826

  • [8] ^ Sriwatanakul, K, W Kelvie, and L Lasagna. 1982. The quantification of pain: an analysis of words used to describe pain and analgesia in clinical trials. Clinical pharmacology and therapeutics, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/7094502

  • [9] ^ Sriwatanakul, K, L Lasagna, and C Cox. 1983. Evaluation of current clinical trial methodology in analgesimetry based on experts’ opinions and analysis of several analgesic studies. Clinical pharmacology and therapeutics, no. 3. https://www.ncbi.nlm.nih.gov/pubmed/6883903

  • [10] ^ Sriwatanakul, K, K McCormick, and P Woolf. 1984. Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists. The Journal of clinical endocrinology and metabolism, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/6420433

  • [11] ^ Sriwatanakul, K, and S R Nahorski. 1980. Disposition and activity of beta-adrenoceptor antagonists in the rat using an ex vivo receptor binding assay. European journal of pharmacology, no. 2-3 ( 29). https://www.ncbi.nlm.nih.gov/pubmed/6108223

  • [12] ^ Wang, Z X, and K Sriwatanakul. 1983. Drugs used for the treatment of dementia. Rational drug therapy, no. 5. https://www.ncbi.nlm.nih.gov/pubmed/6611957

  • [13] ^ Weintraub, M, K Sriwatanakul, P R Sundaresan, O F Weis, and M Dorn. 1983. Extended-release fenfluramine: patient acceptance and efficacy of evening dosing. Clinical pharmacology and therapeutics, no. 5. https://www.ncbi.nlm.nih.gov/pubmed/6340909

  • [14] ^ Weis, O, K Sriwatanakul, and M Weintraub. 1982. Treatment of post-herpetic neuralgia and acute herpetic pain with amitriptyline and perphenazine. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, no. 9 ( 21). https://www.ncbi.nlm.nih.gov/pubmed/7112329

  • [15] ^ Yanapirut, P, and K Sriwatanakul. 1987. Prospective study of adverse reactions of anticancer drugs in Thai patients. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, no. 8. https://www.ncbi.nlm.nih.gov/pubmed/3681169.